Amendment No. 4

Awarded Award Notice Posted

Solicitation number
N44CO47004-13
Agency
National Institutes of Health Department of Health and Human Services
Awarded
to A&G Pharmaceutical, Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
HHSN261201400040C Federal contract award
NAICS code
541711 Research and Development in Biotechnology
PSC
Not on record

Notice details come from SAM.gov. Updated .

Notice text

5 versions

Update #5 · Latest ·

Added: Mar 03, 2014 9:23 am THE DUE DATE OF THE PROPOSAL HAS BEEN EXTENDED TO 3:00PM EASTERN STANDARD TIME (EST), WEDNESDAY, MARCH 5, 2014.

Update #4 ·

Added: Feb 27, 2014 4:16 pm The purpose of this amendment is to:

1). Revise Section 4.1 LIMITATIONS ON LENGTH OF PROPOSAL and;
2). To post the answers to the inquiries that have been submitted to the NCI OA SBIR e-mail address: ncioasbir@mail.nih.gov.


THE DUE DATE OF THE PROPOSAL REMAINS UNCHANGED AT 5:00PM EASTERN STANDARD TIME (EST), MONDAY, MARCH 3, 2014.

Update #3 ·

Added: Feb 25, 2014 1:07 pm The purpose of this amendment is to correct the appendices attachment links and the number of copies of the technical proposal required to be submitted.

The due date of the proposal remains unchanged at 5:00 PM Eastern Standard Time (EST), Monday, March 3, 2014.

Update #2 ·

Added: Jan 29, 2014 1:15 pm

January 29, 2014, Amendment No. 1:  The purpose of this amendment is to extend the closing date to March 3, 2014 and to correct the NCI OA SBIR email address listed on page 36 of Solicitation No. N44CO47004-13. Please see attachment.

Update #1 ·

Added: Jan 10, 2014 3:12 pm

The objectives of the SBIR program include stimulating technological innovation in the private sector, strengthening the role of small business in meeting Federal R/R&D needs, increasing private sector commercialization of innovations developed through Federal SBIR R&D, increasing small business participation in Federal R&D, and fostering and encouraging participation by socially and economically disadvantaged small business concerns and women-owned small business concerns in the SBIR program.


The basic design of the NIH/CDC SBIR program is in accordance with the Small Business Administration (SBA) SBIR Program Policy Directive, 2012 This SBIR Contract solicitation strives to encourage scientific and technical innovation in areas specifically identified by the NIH. The guidelines presented in this solicitation reflect the flexibility provided in the Policy Directive to encourage proposals based on scientific and technical approaches most likely to yield results important to the NIH and to the private sector.


No telephone inquiries will be accepted.  All inquiries must be submitted in writing to ncioasbir@nih.gov no later than February 17, 2014.

Attachments

Files attached to this notice, newest first
File Type Posted
2014_SBIR_Phase_II_Amendment_4_signed.pdf PDF
2014_SBIR_Phase_II_Amendment_3_Posted_FBO.pdf PDF
Summary_of_Proposed_Costs.xls XLS spreadsheet
2014_SBIR_Phase_II_Amendment_2_FBO.pdf PDF
2014_SBIR_Phase_II_Amendment_1_FBO.pdf PDF
2014_SBIR_Phase_II_RFP_01-10-2014.pdf PDF

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity